Has Christopher Wilcox, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,978 in general payments to Christopher Wilcox, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Wilcox, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Wilcox, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Wilcox, MD

Nephrology · Washington, DCNPI 1245231109

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Merck at 55.3% of the total. Reporting peaked in 2019 at $28,343 and has fallen 99.5% since, to $147 in 2025. Among nephrology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,978in general payments, 2019–2025

Across 33 payments — averaging $1241.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$23K
E.r. Squibb & Sons, L.L.C.$9K
Vifor Pharma, Inc.$6K
Sanofi US Services Inc.$2K
AstraZeneca$817
Bayer$225
plus $302 from 3 others

What the payments were for

Consulting fees$12,10830%
Speaking & faculty fees$22,97056%
Travel & lodging$4,16810%
Food & beverage$1,7324%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	2	$22,650
E.r. Squibb & Sons, L.L.C.	3	$8,850
Vifor Pharma, Inc.	18	$5,784
Sanofi US Services Inc.	3	$2,350
AstraZeneca	2	$817
Bayer	2	$225
Travere Therapeutics, Inc.	1	$147
Esperion Therapeutics, Inc.	1	$131
Bristol Myers Squibb	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,978 in reported general payments places this provider in the 90th percentile of 62 nephrology providers in District of Columbia.

See all nephrology providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$10,638

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Washington

Ashte CollinsWashington$1M
Bruce LeslieWashington$217K
Janani RangaswamiWashington$152K
Robert RubinWashington$119K
Ehsan Nobakht HaghighiWashington$50K
Michael LipkowitzWashington$21K
Dominic RajWashington$19K
Cosette JamiesonWashington$13K
Elwin BustosWashington$9K
Antonina KolesnikovaWashington$7K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →